EVISTA 60 mg, comprimé pelliculé — plaquette(s) thermoformée(s) PVC polyéthylène (ACLAR RX) polytrifluorochloroéthylène de 28 comprimé(s) (distributeur parallèle : Laboratoire Mediwin Ldt)

Medicine package · Base de données publique des médicaments (BDPM), ANSM, HAS et Assurance Maladie · France

  • CIP13 3400949503650
  • CIP7 4950365
  • CIS 67365141
  • Registration number EU/1/98/073

What the source publishes

Holder
SUBSTIPHARM
Active ingredients
CHLORHYDRATE DE RALOXIFÈNE, RALOXIFÈNE BASE
Form
comprimé pelliculé
Package
plaquette(s) thermoformée(s) PVC polyéthylène (ACLAR RX) polytrifluorochloroéthylène de 28 comprimé(s) (distributeur parallèle : Laboratoire Mediwin Ldt)
Routes
orale
Administrative status
authorised
Supply regime
liste I
Marketing status
Déclaration de commercialisation
Authorised on
1998-08-05
Prescription
Prescription or restricted

Names this record is found by

Complete source data
fr:ansm:packages:3400949503650
{
  "cis": "67365141",
  "cip7": "4950365",
  "form": "comprimé pelliculé",
  "name": "EVISTA 60 mg, comprimé pelliculé — plaquette(s) thermoformée(s) PVC polyéthylène (ACLAR RX) polytrifluorochloroéthylène de 28 comprimé(s) (distributeur parallèle : Laboratoire Mediwin Ldt)",
  "cip13": "3400949503650",
  "holder": "SUBSTIPHARM",
  "routes": [
    "orale"
  ],
  "holders": [
    "SUBSTIPHARM"
  ],
  "currency": "EUR",
  "marketed": true,
  "bdmStatus": null,
  "useDomain": "unknown",
  "publicPrice": "12.45",
  "authorisedOn": "1998-08-05",
  "compositions": [
    {
      "name": "CHLORHYDRATE DE RALOXIFÈNE",
      "nature": "SA",
      "strength": "60 mg",
      "linkageNumber": "11",
      "substanceCode": "79270",
      "dosageReference": "un comprimé",
      "pharmaceuticalElement": "comprimé"
    },
    {
      "name": "RALOXIFÈNE BASE",
      "nature": "FT",
      "strength": "55,71 mg",
      "linkageNumber": "11",
      "substanceCode": "93678",
      "dosageReference": "un comprimé",
      "pharmaceuticalElement": "comprimé"
    }
  ],
  "sourceStatus": "Présentation active",
  "supplyRegime": "liste I",
  "dispensingFee": "1.02",
  "medicinePrice": "11.43",
  "regionalRules": "not-collected",
  "targetSpecies": [],
  "specialityName": "EVISTA 60 mg, comprimé pelliculé",
  "marketingStatus": "Déclaration de commercialisation",
  "publicationDates": {
    "CIS_bdpm": "2026-01-08",
    "CIS_CIP_bdpm": "2026-11-19",
    "CIS_CPD_bdpm": "2026-01-08",
    "CIS_COMPO_bdpm": "2026-01-08"
  },
  "specialityListed": true,
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "fr.ansm.bdpm"
  },
  "collectiveApproval": "oui",
  "packageDescription": "plaquette(s) thermoformée(s) PVC polyéthylène (ACLAR RX) polytrifluorochloroéthylène de 28 comprimé(s) (distributeur parallèle : Laboratoire Mediwin Ldt)",
  "patientEligibility": "not-assessed",
  "reimbursementRates": [
    "65%"
  ],
  "marketingDeclaredOn": "2012-07-03",
  "targetSpeciesStatus": "not-reported",
  "additionalMonitoring": false,
  "administrativeStatus": "authorised",
  "prescriptionCategory": "prescription-or-restricted",
  "activeIngredientNames": [
    "CHLORHYDRATE DE RALOXIFÈNE",
    "RALOXIFÈNE BASE"
  ],
  "authorisationProcedure": "Procédure centralisée",
  "prescriptionConditions": [
    "liste I"
  ],
  "reimbursementIndications": "Ce médicament peut être pris en charge ou remboursé par l'Assurance Maladie dans les cas suivants :<br><br>- Prévention et traitement de l'ostéoporose postménopausique du rachis, pour réduire le risque de fractures vertébrales, chez les femmes âgées de moins de 70 ans, sans facteur de risque veineux et avec apport de calcium<br> ; JOURNAL OFFICIEL ; 17/05/01",
  "authorisationSourceStatus": "Autorisation active",
  "europeanAuthorisationNumber": "EU/1/98/073",
  "presentationAdministrativeStatus": "authorised"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=fr" \
  --data-urlencode "sourceId=fr.ansm.bdpm" \
  --data-urlencode "id=fr:ansm:packages:3400949503650"